Jyong Biotech (MENS) director Fan Hung-Shu files initial Form 3

Rhea-AI Filing Summary

Jyong Biotech Ltd. director Fan Hung-Shu filed an initial statement of beneficial ownership on Form 3 for company shares. The filing establishes this person’s insider status as a director but does not report any insider purchase, sale, or other transaction in the issuer’s securities.

Key Terms

Form 3, beneficial ownership, insider

3 terms

Form 3 regulatory

"filed an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"filed an initial statement of beneficial ownership on Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

insider financial

"establishes this person’s insider status as a director"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Fan Hung-Shu

(Last) (First) (Middle)

23F-3, NO.95, SEC. 1, XINTAI 5TH RD.

(Street)

NEW TAIPEI CITY TAIWAN, PROVINCE OF CHINA 221

(City) (State) (Zip)

TAIWAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/01/2026

3. Issuer Name and Ticker or Trading Symbol
Jyong Biotech Ltd. [ MENS ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Fan Hung-Shu	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Jyong Biotech Ltd. (MENS) Form 3 filed by Fan Hung-Shu mean?

The Form 3 shows that Fan Hung-Shu is an insider of Jyong Biotech Ltd. as a director. It is an initial beneficial ownership report and, in this case, does not list any insider stock transactions or derivative positions.

Did Jyong Biotech (MENS) director Fan Hung-Shu buy or sell shares in this Form 3?

No insider buying or selling is reported in this Form 3. The filing only records Fan Hung-Shu’s status as a director of Jyong Biotech Ltd., without disclosing any purchases, sales, or option exercises in company securities.

Does the MENS Form 3 for Fan Hung-Shu show any derivative securities or options?

The Form 3 derivative section is empty for this filing. That indicates no reportable options, warrants, or other derivative securities are shown for Fan Hung-Shu in this initial beneficial ownership statement for Jyong Biotech Ltd.

Is the Form 3 for Jyong Biotech (MENS) a trading signal for investors?

This Form 3 is largely administrative, confirming insider status rather than signaling trading activity. Since it reports no purchases, sales, or derivative exercises, it does not by itself indicate a bullish or bearish view on Jyong Biotech Ltd. shares.

Why is Jyong Biotech Ltd. (MENS) director Fan Hung-Shu required to file Form 3?

Directors, officers, and certain large shareholders must file Form 3 when they first become insiders. This filing identifies Fan Hung-Shu as a director of Jyong Biotech Ltd., helping the market track any future reportable transactions in company securities.